{
  "id": 7308468,
  "title": "AstraZeneca’s next-gen SERD Etcamah disappoints in untreated advanced breast cancer",
  "url": "https://urgent.news/2026/09/14/astrazenecas-next-gen-serd-etcamah-disappoints-in-untreated-advanced",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T11:21:38.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/astrazenecas-next-gen-serd-etcamah-disappoints-in-untreated-advanced-breast-cancer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "AstraZeneca said Friday that its recently approved breast cancer drug Etcamah failed a late-stage trial designed to support a label expansion into an earlier setting. Just last week, the FDA cleared the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}